Cardiac Care and COVID-19: Perspectives in Medical Practice

Author(s): Ozgur KARCIOGLU * .

DOI: 10.2174/9781681088204121010003

Cardiovascular Disease and COVID-19

Pp: 6-18 (13)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

Cardiovascular disease (CVD) has long been the leading cause of global morbidity and mortality. However, with the COVID-19 pandemic, which has been the focus of attention all over the world since the end of 2019, this issue has gained different importance. The presence of CVD leads to more severe COVID-19 and an increased probability of mortality. In addition, both CVD and COVID-19 pave the way to myocardial injury, which also boosts the morbidity and death toll. Another point is the possible deprivation of usual healthcare received by cardiac patients (CVD and others) because of the shifted emphasis of the hospital and prehospital medical services on COVID-19. As the public can foresee that the pandemic will not disappear rapidly soon, healthcare organization faces a challenge to be redesigned radically. The objective of this chapter is to analyze CVD, myocardial injury, and other cardiac diseases resulting from COVID-19 itself, together with the impact of the pandemics on the usual healthcare of cardiac patients.

Recommended Chapters

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books